Specialty Pharmacy

Clinical trial demonstrates adoptive T-cell therapy may be successful in treating progressive multifocal leukoencephalopathy.

California’s tobacco control programs have lowered lung cancer deaths 33% faster than the rest of the United States.

Report analyzes HIV-related stigma among health care providers and the potential impact on quality of patient care.

Top news of the day from across the health care landscape.

Broadly neutralizing antibodies have one key advantage over antiretroviral therapy: they have a longer half-life and thus don’t require the daily, lifelong dosing regimen currently required of ART users.

Survey participants reported need for better education on how brain atrophy affects multiple sclerosis progression and cognitive loss.

Olaparib (Lynparza, AstraZeneca and Merck), which is being investigated for the treatment of prostate cancer, receives its fourth orphan drug designation from the FDA.

Top news of the day from across the health care landscape.

Officials with the Centers for Medicare & Medicaid Services this week proposed requiring drug manufacturers to include prices in direct-to-consumer television advertisements for prescription drugs.

Talazoparib is indicated for patients with known deleterious or suspected deleterious germline BRCA-mutated HER2-negative locally advanced or metastatic breast cancer.

Aspirin dose and duration of use may affect the risk of developing ovarian cancer and hepatocellular cancer.

Neoadjuvant therapy with a combination checkpoint blockade produced a high response rate among patients with melanoma.

Top news of the day from across the health care landscape.

Study investigates whether direct-acting antiviral drugs for hepatitis C virus increase the risk of developing hepatocellular carcinoma.

The benefits of adopting blockchain technology have not been overlooked by the health care industry and can have a direct and lasting impact on specialty pharmacy.

Obesity and weight gain in early adulthood may be a contributor to increased risk of early-onset colorectal cancer in women under the age of 50.

Mike Agostino, RPh, President of the National Association of Specialty Pharmacy (NASP), discusses how NASP has grown to meet the evolving needs of the pharmacy profession.

Top news of the day from across the health care landscape.

Fingolimod (Gilenya) found to significantly reduce the annualized relapse rate compared with glatiramer acetate among patients with relapsing-remitting multiple sclerosis.

On the first National Women Pharmacists Day, top voices in the field discuss how women are helping to shape the future of pharmacy.

Top news of the day from across the health care landscape.

A look at last week's top stories in the world of pharmacy.

Puerto Rico’s Hispanic population faces substantially different cancer risks compared with Hispanics in the continental United States.

Top news of the day from across the health care landscape.

Researchers investigated the impact of individual types of human papilloma virus on HIV acquisition.

New 5-year data from phase 3 studies show that patients treated earlier with ocrelizumab (Ocrevus) had better outcomes on multiple measures of multiple sclerosis disease activity.

The national Veterans Health Administration Corporate Data Warehouse could be key in revealing accurate data on the use of direct-acting antivirals in the treatment of chronic hepatitis C virus.

Insurers and pharmacy benefit managers can no longer restrict pharmacies from providing drug price information to customers.